- Home
- LDTC vs BGLC Comparison
LDTC vs BGLC Comparison
Compare LDTC & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LDTC
- BGLC
- Stock Information
- Founded
- LDTC 2007
- BGLC 2017
- Country
- LDTC Canada
- BGLC Malaysia
- Employees
- LDTC N/A
- BGLC N/A
- Industry
- LDTC Blank Checks
- BGLC Medical Specialities
- Sector
- LDTC Finance
- BGLC Health Care
- Exchange
- LDTC Nasdaq
- BGLC Nasdaq
- Market Cap
- LDTC 7.9M
- BGLC 7.6M
- IPO Year
- LDTC N/A
- BGLC N/A
- Fundamental
- Price
- LDTC $0.32
- BGLC $0.30
- Analyst Decision
- LDTC Buy
- BGLC
- Analyst Count
- LDTC 3
- BGLC 0
- Target Price
- LDTC $1.00
- BGLC N/A
- AVG Volume (30 Days)
- LDTC 157.6K
- BGLC 78.7K
- Earning Date
- LDTC 08-14-2024
- BGLC 11-20-2024
- Dividend Yield
- LDTC N/A
- BGLC N/A
- EPS Growth
- LDTC N/A
- BGLC N/A
- EPS
- LDTC N/A
- BGLC N/A
- Revenue
- LDTC $6,052,694.00
- BGLC $9,183,168.00
- Revenue This Year
- LDTC N/A
- BGLC N/A
- Revenue Next Year
- LDTC $2.28
- BGLC N/A
- P/E Ratio
- LDTC N/A
- BGLC N/A
- Revenue Growth
- LDTC 2.76
- BGLC N/A
- 52 Week Low
- LDTC $0.22
- BGLC $0.28
- 52 Week High
- LDTC $11.20
- BGLC $3.39
- Technical
- Relative Strength Index (RSI)
- LDTC 59.16
- BGLC 24.52
- Support Level
- LDTC $0.28
- BGLC $0.32
- Resistance Level
- LDTC $0.35
- BGLC $0.38
- Average True Range (ATR)
- LDTC 0.04
- BGLC 0.02
- MACD
- LDTC 0.01
- BGLC -0.00
- Stochastic Oscillator
- LDTC 75.97
- BGLC 18.27
About LDTC LeddarTech Holdings Inc.
LeddarTech Holdings Inc is a company that develops and provides comprehensive perception software solutions that enable the deployment of ADAS and autonomous driving (AD) applications. Its automotive-grade software applies AI and computer vision algorithms to generate accurate 3D models of the environment, allowing for decision-making and safer navigation.
About BGLC BioNexus Gene Lab Corp Common stock
BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.